Copyright Reports & Markets. All rights reserved.

Global Androgenic Alopecia Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Medicine
      • 1.4.3 Surgery
      • 1.4.4 Other
    • 1.5 Market by Application
      • 1.5.1 Global Androgenic Alopecia Therapeutics Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Androgenic Alopecia Therapeutics Market Size
    • 2.2 Androgenic Alopecia Therapeutics Growth Trends by Regions
      • 2.2.1 Androgenic Alopecia Therapeutics Market Size by Regions (2019-2025)
      • 2.2.2 Androgenic Alopecia Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Androgenic Alopecia Therapeutics Market Size by by Players
      • 3.1.1 Global Androgenic Alopecia Therapeutics Revenue by by Players (2014-2019)
      • 3.1.2 Global Androgenic Alopecia Therapeutics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Androgenic Alopecia Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Androgenic Alopecia Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Androgenic Alopecia Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Androgenic Alopecia Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Androgenic Alopecia Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Androgenic Alopecia Therapeutics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Androgenic Alopecia Therapeutics Market Size (2014-2019)
    • 5.2 Androgenic Alopecia Therapeutics Key Players in North America
    • 5.3 North America Androgenic Alopecia Therapeutics Market Size by Type
    • 5.4 North America Androgenic Alopecia Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Androgenic Alopecia Therapeutics Market Size (2014-2019)
    • 6.2 Androgenic Alopecia Therapeutics Key Players in Europe
    • 6.3 Europe Androgenic Alopecia Therapeutics Market Size by Type
    • 6.4 Europe Androgenic Alopecia Therapeutics Market Size by Application

    7 China

    • 7.1 China Androgenic Alopecia Therapeutics Market Size (2014-2019)
    • 7.2 Androgenic Alopecia Therapeutics Key Players in China
    • 7.3 China Androgenic Alopecia Therapeutics Market Size by Type
    • 7.4 China Androgenic Alopecia Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Androgenic Alopecia Therapeutics Market Size (2014-2019)
    • 8.2 Androgenic Alopecia Therapeutics Key Players in Japan
    • 8.3 Japan Androgenic Alopecia Therapeutics Market Size by Type
    • 8.4 Japan Androgenic Alopecia Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Androgenic Alopecia Therapeutics Market Size (2014-2019)
    • 9.2 Androgenic Alopecia Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Androgenic Alopecia Therapeutics Market Size by Type
    • 9.4 Southeast Asia Androgenic Alopecia Therapeutics Market Size by Application

    10 India

    • 10.1 India Androgenic Alopecia Therapeutics Market Size (2014-2019)
    • 10.2 Androgenic Alopecia Therapeutics Key Players in India
    • 10.3 India Androgenic Alopecia Therapeutics Market Size by Type
    • 10.4 India Androgenic Alopecia Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Androgenic Alopecia Therapeutics Market Size (2014-2019)
    • 11.2 Androgenic Alopecia Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Androgenic Alopecia Therapeutics Market Size by Type
    • 11.4 Central & South America Androgenic Alopecia Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Johnson & Johnson
      • 12.1.1 Johnson & Johnson Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Androgenic Alopecia Therapeutics Introduction
      • 12.1.4 Johnson & Johnson Revenue in Androgenic Alopecia Therapeutics Business (2014-2019))
      • 12.1.5 Johnson & Johnson Recent Development
    • 12.2 Merck
      • 12.2.1 Merck Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Androgenic Alopecia Therapeutics Introduction
      • 12.2.4 Merck Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.2.5 Merck Recent Development
    • 12.3 GlaxoSmithKline
      • 12.3.1 GlaxoSmithKline Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Androgenic Alopecia Therapeutics Introduction
      • 12.3.4 GlaxoSmithKline Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.3.5 GlaxoSmithKline Recent Development
    • 12.4 Astellas Pharma
      • 12.4.1 Astellas Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Androgenic Alopecia Therapeutics Introduction
      • 12.4.4 Astellas Pharma Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.4.5 Astellas Pharma Recent Development
    • 12.5 Cipla
      • 12.5.1 Cipla Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Androgenic Alopecia Therapeutics Introduction
      • 12.5.4 Cipla Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.5.5 Cipla Recent Development
    • 12.6 Almirall
      • 12.6.1 Almirall Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Androgenic Alopecia Therapeutics Introduction
      • 12.6.4 Almirall Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.6.5 Almirall Recent Development
    • 12.7 Sun Pharma
      • 12.7.1 Sun Pharma Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Androgenic Alopecia Therapeutics Introduction
      • 12.7.4 Sun Pharma Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.7.5 Sun Pharma Recent Development
    • 12.8 Reddy's Laboratories
      • 12.8.1 Reddy's Laboratories Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Androgenic Alopecia Therapeutics Introduction
      • 12.8.4 Reddy's Laboratories Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.8.5 Reddy's Laboratories Recent Development
    • 12.9 Concert Pharmaceuticals
      • 12.9.1 Concert Pharmaceuticals Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Androgenic Alopecia Therapeutics Introduction
      • 12.9.4 Concert Pharmaceuticals Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.9.5 Concert Pharmaceuticals Recent Development
    • 12.10 RiverTown Therapeutics
      • 12.10.1 RiverTown Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Androgenic Alopecia Therapeutics Introduction
      • 12.10.4 RiverTown Therapeutics Revenue in Androgenic Alopecia Therapeutics Business (2014-2019)
      • 12.10.5 RiverTown Therapeutics Recent Development
    • 12.11 Brickell Biotech
    • 12.12 BiologicsMD
    • 12.13 Aclaris Therapeutics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Androgenic Alopecia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Androgenic Alopecia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Johnson & Johnson
      Merck
      GlaxoSmithKline
      Astellas Pharma
      Cipla
      Almirall
      Sun Pharma
      Reddy's Laboratories
      Concert Pharmaceuticals
      RiverTown Therapeutics
      Brickell Biotech
      BiologicsMD
      Aclaris Therapeutics

      Market segment by Type, the product can be split into
      Medicine
      Surgery
      Other

      Market segment by Application, split into
      Hospital
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Androgenic Alopecia Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Androgenic Alopecia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Androgenic Alopecia Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now